Healthcare Services Group, Inc.
NASDAQ:HCSGMedical - Care Facilities
+$0.39 today
- Market cap
- $1.69B
- Beta
- 0.83
- P/E (TTM)
- 23.4
- EPS (TTM)
- $0.97
Volume 0.62M
Average 0.69M
HCSG Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Healthcare Services Group, Inc.NASDAQ: HCSG
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables turns negative
Q1 FY2026 accounts receivables was -$15.17M, compared with $2.24M a year earlier. Trailing-twelve-month accounts receivables was -$12.18M.
Context
- Accounts receivables amounted to 0.3% of revenue in FY2025, down 3.3 pp from a year earlier.
- Accounts receivables increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts receivables holds near -$15.17M or moves back toward the trailing-twelve-month quarterly average of -$3.05M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 5.23M USD
- Year-over-year change
- +108.5%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.23M | +108.5% |
| FY2024 | 2024-12-31 | (61.81M) | +17.1% |
| FY2023 | 2023-12-31 | (74.56M) | +5.3% |
| FY2022 | 2022-12-31 | (78.71M) | -111.7% |
| FY2021 | 2021-12-31 | (37.19M) | — |
Accounts Receivables vs competitors
How HCSG compares with its peers on the latest reported figures
- HCSG's LTM Mar 2026 accounts receivables of $12.18M is the 5th largest of the 11 companies compared; the peer median is $5.86M.
- Its year-over-year change of -148.1% is the 9th highest of 10, against a peer median of -44.3%.
- Accounts receivables amounts to 0.7% of revenue for HCSG, versus a peer median of 1.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $73.42M | -44.3% | -37.4% | 12.3% | |
| LTM Mar 2026 | $70.81M | +361.4% | — | 9.0% | |
| LTM Mar 2026 | $45.19M | -535.3% | -4.7% | 0.8% | |
| LTM Apr 2026 | $25.35M | +2637.1% | — | 0.9% | |
| LTM Mar 2026 | $12.18M | -148.1% | — | 0.7% | |
| LTM Mar 2026 | $10.98M | +206.8% | -4.1% | 1.5% | |
| LTM Mar 2026 | $10.3M | -57.9% | +305.9% | 1.0% | |
| LTM Jan 2026 | $8.99M | +37.6% | — | 10.7% | |
| LTM Mar 2026 | $2.74M | -115.0% | -23.2% | 0.2% | |
| LTM Aug 2026 | $407K | -101.7% | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | — | |
| Peer median (excluding HCSG) | $5.86M | -44.3% | -4.7% | 1.0% | |
Competitors are the stored peer set for HCSG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 45.86M | 34.63M | 38.39M | 39.47M | 59.06M |
| Depreciation & Amortization | 14.67M | 15.32M | 14.34M | 14.59M | 17.07M |
| Deferred Income Tax | 3.07M | 5.05M | (4.82M) | (2.94M) | 19.2M |
| Stock-Based Compensation | 8.83M | 9.21M | 8.99M | 9.17M | 12.01M |
| Change in Working Capital | (43.15M) | (114.77M) | (44.16M) | (70.19M) | (40.55M) |
| Accounts Receivables | (37.19M) | (78.71M) | (74.56M) | (61.81M) | 5.23M |
| Inventory | 5.6M | 4.85M | 2.69M | 1.73M | (48K) |
| Accounts Payables | 10.24M | (13.75M) | 7.43M | (9.74M) | (12.06M) |
| Other Working Capital | (21.81M) | (27.17M) | 20.28M | (374K) | (33.66M) |
| Other Non-Cash Items | 7.83M | 42.4M | 30.77M | 40.72M | 78.18M |
| Operating Cash Flow | 37.11M | (8.17M) | 43.5M | 30.8M | 144.97M |
| Capital Expenditures | (5.69M) | (5.21M) | (5.41M) | (6.34M) | (5.82M) |
| Acquisitions (Net) | (23.88M) | (114K) | 0 | (2.75M) | (7.15M) |
| Purchases of Investments | (20.34M) | (2.88M) | 0 | (52.09M) | (21.34M) |
| Sales of Investments | 26.7M | 10.39M | 1.99M | 67.01M | 23.21M |
| Other Investing Activities | 211K | 393K | 121K | 211K | 105K |
| Investing Cash Flow | (22.99M) | 2.58M | (3.29M) | 6.05M | (11M) |
| Debt Repayment | 0 | 25M | 0 | (25M) | 0 |
| Common Stock Issued | 92K | 106K | 0 | 0 | 0 |
| Common Stock Repurchased | (21.54M) | 0 | (11.28M) | (5.02M) | (61.59M) |
| Dividends Paid | (62.23M) | (63.37M) | 0 | 0 | 0 |
| Other Financing Activities | 1.02M | (661K) | (871K) | (1.03M) | (1.74M) |
| Financing Cash Flow | (82.65M) | (38.93M) | (12.15M) | (31.05M) | (63.33M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (68.54M) | (44.52M) | 28.05M | 5.8M | 70.64M |
| Free Cash Flow | 31.42M | (13.38M) | 38.09M | 24.47M | 139.15M |
Healthcare Services Group, Inc.
NASDAQ:HCSG
Intrinsic Alpha fair value
Locked
Current Price
$25.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.